MLAB vs CGNX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MLAB · Mesa Laboratories$127.93 ▼ 4.11%
CGNX · Cognex$44.36 ▼ 6.92%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MLAB +72.7%
- CGNX +28.9%
Head to head
| Metric | MLAB | CGNX |
|---|---|---|
| Price | $127.93 | $44.36 |
| Change today | ▼ 4.11% | ▼ 6.92% |
| Market cap | $719.03M | $7.47B |
| Return, 3 months | +3.0% | -26.7% |
| Return, year to date | +63.7% | +23.8% |
| Return, 1 year | +82.4% | +27.8% |
| P/E (TTM) | 110.3 | 31.0 |
| P/B | 3.7 | 4.3 |
| P/E percentile vs own 5y | 59th | 10th |
| Dividend yield | 0.50% | 0.77% |
| Revenue growth (YoY, latest qtr) | +2.6% | +13.2% |
| Net profit growth (YoY) | +75.3% | +380.2% |
| Gross margin | 64.8% | 69.7% |
| Operating margin | 10.4% | 25.0% |
| Net margin | 2.7% | 21.5% |
| Return on equity | 3.6% | 15.1% |
| Analyst target vs. price | +17.3% | +60.2% |
| Analyst buy share | 100% | 69% |
| RSI (14) | 47 | 36 |
| 30-day volatility | 49.5% | 60.6% |
| Max drawdown, 1 year | -24.2% | -34.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CGNX is the largest of the group by market value.
- MLAB has returned the most over the past year.
- CGNX carries the lowest trailing P/E.
- CGNX pays the highest dividend yield.
- CGNX is growing revenue fastest.
- CGNX keeps the most profit per dollar of sales.
- MLAB has been the calmest stock over the last 30 days.